Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T63480 |
COX-2-IN-26
|
||
COX-2-IN-26 是有效的、口服具有活力的、选择性的 COX-2 抑制剂,能够作用于 COX-1 (IC50: 10.61 μM)、COX-2 (IC50: 0.067 μM)、15-LOX (IC50: 1.96 μM)。COX-2-IN-26 具有抗炎作用,具有胃肠道安全性。 | |||
T1185 |
Rofecoxib
MK 966,罗非昔布,罗非考昔,MK-0966 |
COX | Immunology/Inflammation; Neuroscience |
Rofecoxib (MK 966) 是可口服的 COX-2特异性抑制剂,具有抗炎、解热和镇痛特性以及潜在的抗肿瘤特性。在人骨肉瘤细胞和中国仓鼠卵巢细胞中,对人 COX-2 的 IC50值分别为 26 和 18 nM。 | |||
T0839 |
Ketoprofen
酮基布洛芬,RP-19583,酮洛芬 |
Apoptosis; COX; MRP | Apoptosis; Immunology/Inflammation; Neuroscience |
Ketoprofen (RP-19583) 是一种非甾体抗炎剂,能够有效地抑制COX 的活性,在人血单核细胞中,对 COX-1 和 COX-2 的IC50值分别为 2 nM 和 26 nM。 | |||
T11655 |
Indomethacin-D4
Indometacin-D4,吲哚美辛-D4 |
CDK | Cell Cycle/Checkpoint |
Indomethacin-D4 is a deuterium labeled Indomethacin. Indomethacin is a potent and nonselective inhibitor of COX1 and COX2, with IC50s of 18 nM and 26 nM for human COX-1 and COX-2, respectively, in CHO cells. | |||
T61606 |
Indomethacin sodium
|
||
Indomethacin sodium, a powerful and orally active inhibitor of COX1/2, exhibits IC50 values of 18 nM and 26 nM for COX-1 and COX-2, respectively. Apart from its potent anti-inflammatory effects, this compound possesses notable anticancer and anti-infective activities. Since it has such versatile attributes, it finds useful applicability in cancer, inflammation, and viral infection research [1] [2] [3]. |